ArticleInternational journal of molecular medicine2026
[Expression of Concern] ISL1 promotes cancer progression and inhibits cisplatin sensitivity in triple‑negative breast cancer cells.
Yang Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.